Changgui Lan has completed his MD from Luzhou Medical College and MSc from West China Hospital of Sichuan University and Postdoctoral studies from Columbia University Medical Center and New York University, School of Medicine. He is the Director of Department of Dermatology at China National Nuclear Corporation 416 Hospital and the 2nd Affiliated Hospital of Chengdu Medical College, Sichuan Province, China. He has published more than 30 papers in English journals and Chinese journals. He has specialized in research of pretibial myxedema from epidemiology, clinical manifestation and diagnosis to treatment. He has published 5 papers about pretibial myxedema and his PTM patient numbers are the biggest in the world Changgui Lan has completed his MD from Luzhou Medical College and MSc from West China Hospital of Sichuan University and Postdoctoral studies from Columbia University Medical Center and New York University, School of Medicine. He is the Director of Department of Dermatology at China National Nuclear Corporation 416 Hospital and the 2nd Affiliated Hospital of Chengdu Medical College, Sichuan Province, China. He has published more than 30 papers in English journals and Chinese journals. He has specialized in research of pretibial myxedema from epidemiology, clinical manifestation and diagnosis to treatment. He has published 5 papers about pretibial myxedema and his PTM patient numbers are the biggest in the world

Research of pretibial myxedema from epidemiology, clinical manifestation and diagnosis to treatmen